Advertisement
News
Subscribe to MDT Magazine News

Boeing names Aetna chairman to its board

December 2, 2010 1:45 pm | by The Associated Press | Comments

Boeing Co. said on Thursday that Aetna Inc. Chairman and former CEO Ronald A. Williams has become a Boeing director.Williams, 61, stepped down as Aetna CEO last month. He joined Aetna as executive vice president and chief of health operations in 2001, and was named CEO in February 2006. Boeing...

Better imaging from bench to bedside

December 2, 2010 1:33 pm | by EurekAlert | Comments

(European Molecular Biology Laboratory) Euro-BioImaging, a project which launches its preparatory phase today, aims to provide scientists throughout Europe with open access to state-of-the-art imaging technologies at all levels of biological and biomedical research, from bench to bedside.

TOPICS:

SAGE expands Therapeutic Advances series

December 2, 2010 1:33 pm | by EurekAlert | Comments

(SAGE Publications UK) SAGE has extended its suite of Therapeutic Advances journals with the launch of a further two titles: Therapeutic Advances in Drug Safety, and Therapeutic Advances in Hematology.

TOPICS:
Advertisement

WellPoint maintains its 2010 profit forecast

December 2, 2010 12:45 pm | by The Associated Press | Comments

Health insurer WellPoint Inc. said Thursday it will back its annual profit forecast during meetings with analysts and investors over the next few days.The company said in November that it expected a profit of at least $6.60 per share in 2010. In a filing with the Securities and Exchange...

Lower occurrence of atopic dermatitis in children thanks to farm animals and cats

December 2, 2010 11:38 am | by EurekAlert | Comments

(University of Zurich) Children whose mothers are exposed to farm animals and cats are better protected against atopic dermatitis and are less likely to develop this painful inflammation of the skin in their first two years of life. A group of researchers from the University of...

TOPICS:

Grant launches cervical cancer-free Indiana initiative

December 2, 2010 11:37 am | by EurekAlert | Comments

(Indiana University School of Medicine) Indiana will join a multi-state program focused on cervical cancer prevention thanks to an unrestricted gift from GlaxoSmithKline Pharmaceuticals to the Indiana University School of Medicine, in partnership with the Kristen Forbes EVE...

TOPICS:

Obama Administration Officials Unveil GreenGov Supply Chain Partnership with Industry

December 2, 2010 8:35 am | by Material Handling Industry of America | Comments

The U.S. General Services Administration (GSA) announced the GreenGov Supply Chain Partnership and Small Business Pilot, a voluntary collaboration between the federal government and its suppliers to create a greener, more efficient supply chain. The program

Curemark Announces Four New Sites Participating in Autism Study

December 2, 2010 8:34 am | by Bio-Medicine.Org | Comments

RYE, N.Y., Dec. 2, 2010 /- Curemark, LLC , ( www.curemark.com ), a drug research and development company focused on the treatment of neurological diseases, announced that four additional sites across the country are now participating in Phase III clinical trials for the company's autism...

TOPICS:
Advertisement

OrbusNeich's Genousâ„¢ Stent Shows Favorable Outcomes for Treatment of Coronary Artery Bifurcation Lesions Compared to Bare Metal Stents

December 2, 2010 8:33 am | by Bio-Medicine.Org | Comments

HONG KONG, Dec. 2, 2010 /- OrbusNeich's Genous Stent shows favorable outcomes compared to bare metal stents (BMS) for the treatment of coronary artery bifurcation lesions, according to data published online in the journal Atherosclerosis . The cumulative rate of the study's primary...

TOPICS:

Omnicare could raise $560M from senior note sale

December 2, 2010 7:46 am | by The Associated Press | Comments

Omnicare Inc. said Thursday it is hoping to raise as much as $560 million by selling up to $575 million in convertible senior notes due in 2025.The seller of prescription drugs to nursing homes and long-term care facilities said it priced an offering of $500 million in senior notes, which could...

PlasmaButton therapy offers less invasive treatment for benign prostatic hyperplasia

December 2, 2010 7:40 am | by EurekAlert | Comments

(GolinHarris NY) Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products among other core businesses, announced today that its revolutionary PlasmaButton vaporization technology can now be used with the Gyrus ACMI...

TOPICS:

The race against age

December 2, 2010 7:40 am | by EurekAlert | Comments

(Deutsches Aerzteblatt International) Impairments to health and physical performance are not primarily a result of aging but of unfavorable lifestyle habits and lack of exercise. This is the position taken by Dieter Leyk and his coauthors in the new issue of Deutsches Arzteblatt...

TOPICS:

New Report Indicates VERILASTâ„¢ Technology From Smith & Nephew Orthopaedics has Lowest Revision Rate Among all Hip Replacement Materials

December 2, 2010 7:38 am | by Bio-Medicine.Org | Comments

MEMPHIS, Tenn., Dec. 2, 2010 /- A newly released patient registry reports that hip replacement implants made from ceramicized metal heads which articulate against polyethylene lined cups have been shown to have superior survivorship compared to implants made from any other material five...

TOPICS:

FDA Clears GeNO LLC's Investigational New Drug Application for Clinical Trials With Its NITROSYLâ„¢ Inhaled Nitric Oxide System

December 2, 2010 7:35 am | by Bio-Medicine.Org | Comments

COCOA, Fla., Dec. 2, 2010 /- GeNO LLC ( www.genollc.com ), a privately held, advanced development-stage technology company, announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for a clinical trial with the GeNO...

TOPICS:

Dawson James Initiates Research Coverage of Advanced Life Sciences

December 2, 2010 7:35 am | by Bio-Medicine.Org | Comments

CHICAGO, Dec. 2, 2010 /- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS ), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading